Certain H Shares of Cryofocus Medtech (Shanghai) Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-DEC-2023. These H Shares will be under lockup for 365 days starting from 29-DEC-2022 to 29-DEC-2023.

Details:
Pursuant to the Hong Kong Underwriting Agreement, our Company has undertaken to the Joint Sponsors, the Joint Representatives, Joint Global Coordinators, the Joint Bookrunners, the Joint Lead Managers and the Hong Kong Underwriters and each of them not to (save for the issue, offer or sale of the Offer Shares by our Company pursuant to the Global Offering), without the prior written consent of the Joint Sponsors and the Joint Representatives (for themselves and on behalf of the Hong KongUnderwriters) and unless in compliance with the Listing Rules and applicable PRC Laws, at any time during the period commencing on the date of the Hong Kong Underwriting Agreement and ending on, and including, the last date of the six months after the Listing Date (the ?First Six-Month Period?).

In the event that, at any time during the period of six months immediately following the expiration of the First Six-Month Period (the ?Second Six-Month Period?), our Company enters into any of the transactions specified above or offers or agrees or contracts to, or announces, or publicly discloses, any intention to, enter into any such transactions, our Company will take all reasonable steps to ensure that it will not create a disorderly or false market in the Shares or other securities of our Company.